Skip to main content

Table 6 The univariate and multivariate analyses predicting IPSS recovery at 12 months after seed implantation

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Univariate Multiivariate
  p-value Odds ratio p-value Odds ratio 95% C.I.
Neo-ADT 0.081 0.510 n.s.   
EBRT 0.036 2.367 n.s.   
PV at post-dosimetry (mL) 0.066 0.957 n.s.   
D90(Gy) 0.018 0.984 n.s.   
UD30(Gy) 0.008 0.986 0.006 0.986 0.957-0.996
  1. Neo ADT: neoadjuvant androgen deprivation therapy, EBRT: external beam radiation therapy, PV: prostate volume, D90: minimal dose (Gy) received by 90% of the prostate gland, UD30: minimal dose (Gy) received by 30% of the urethra.